Do you have adult patients living with generalized anxiety disorder?

A Phase 3 study evaluating the efficacy and safety of investigational MM120 (100 μg) versus placebo in adults with generalized anxiety disorder in the United States (U.S.)

Click here to learn more

A Phase 3 study evaluating the efficacy and safety of investigational MM120 (100 μg and 50 μg) versus placebo in adults with generalized anxiety disorder in the United States (U.S.) and Europe

Click here to learn more